相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Derivation and investigation of the first human cell-based model of Beckwith-Wiedemann syndrome
Suhee Chang et al.
EPIGENETICS (2021)
Genetic and epigenetic basis of hepatoblastoma diversity
Genta Nagae et al.
NATURE COMMUNICATIONS (2021)
Cancer incidence and spectrum among children with genetically confirmed Beckwith-Wiedemann spectrum in Germany: a retrospective cohort study
Suemeyye Coektue et al.
BRITISH JOURNAL OF CANCER (2020)
Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/FOXO3/ABCB1 axis
Jin Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
Juan Carrillo-Reixach et al.
JOURNAL OF HEPATOLOGY (2020)
Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets
Masahiro Sekiguchi et al.
NPJ PRECISION ONCOLOGY (2020)
Characterization of the Beckwith-Wiedemann spectrum: Diagnosis and management
Kelly A. Duffy et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2019)
Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis
Miao Lu et al.
BMC CANCER (2019)
Incidence trends and survival prediction of hepatoblastoma in children: a population-based study
Jincheng Feng et al.
CANCER COMMUNICATIONS (2019)
The landscape of genomic alterations across childhood cancers
Susanne N. Groebner et al.
NATURE (2018)
Epidermal YAP activity drives canonical WNT16/β-catenin signaling to promote keratinocyte proliferation in vitro and in the murine skin
Veronica Mendoza-Reinoso et al.
STEM CELL RESEARCH (2018)
Hypermethylated KCNQ1 acts as a tumor suppressor in hepatocellular carcinoma
Haiyan Fan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Genomic Analysis of Hepatoblastoma Identifies Distinct Molecular and Prognostic Subgroups
Pavel Sumazin et al.
HEPATOLOGY (2017)
Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma
Jennifer M. Kalish et al.
CLINICAL CANCER RESEARCH (2017)
(Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome
Alessandro Mussa et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4
Surbhi Chouhan et al.
SCIENTIFIC REPORTS (2016)
Exome Sequencing of Hepatoblastoma Reveals Novel Mutations and Cancer Genes in the Wnt Pathway and Ubiquitin Ligase Complex
Deshui Jia et al.
HEPATOLOGY (2014)
The genomic landscape of hepatoblastoma and their progenies with HCC-like features
Melanie Eichenmüller et al.
JOURNAL OF HEPATOLOGY (2014)
Hepatoblastoma in Children With Beckwith-Wiedemann Syndrome: Does it Warrant Different Treatment?
Angela D. Trobaugh-Lotrario et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2014)
Methylation analysis and diagnostics of Beckwith-Wiedemann syndrome in 1,000 subjects
Abdulla Ibrahim et al.
CLINICAL EPIGENETICS (2014)
Case-control study of birth characteristics and the risk of hepatoblastoma
Julia E. Heck et al.
CANCER EPIDEMIOLOGY (2013)
Myc Target miRs and Liver Cancer: Small Molecules to Get Myc Sick
Marie-Annick Buendia et al.
GASTROENTEROLOGY (2012)
Loss of Heterozygosity on Chromosome 11p15.5 and Relapse in Hepatoblastomas
S. Chitragar et al.
EUROPEAN JOURNAL OF PEDIATRIC SURGERY (2011)
Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma
S. Honda et al.
BRITISH JOURNAL OF CANCER (2008)
Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer
Stefano Cairo et al.
CANCER CELL (2008)
Whole-genome profiling of chromosomal aberrations in hepatoblastoma using high-density single-nucleotide polymorphism genotyping microarrays
Makoto Suzuki et al.
CANCER SCIENCE (2008)
The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients
Shohei Honda et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Japanese and North American/European patients with Beckwith Wiedemann syndrome have different frequencies of some epigenetic and genetic alterations
Kensaku Sasaki et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2007)
Elevated expression of Wnt antagonists is a common event in hepatoblastomas
A Koch et al.
CLINICAL CANCER RESEARCH (2005)
Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS)
J Bliek et al.
JOURNAL OF PEDIATRICS (2004)
Beckwith-Wiedemann syndrome-associated hepatoblastoma: Wnt signal activation occurs later in tumorigenesis in patients with 11p15.5 uniparental disomy
R Fukuzawa et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2003)
Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1
R Weksberg et al.
HUMAN MOLECULAR GENETICS (2001)
p57KIP2 is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57KIP2, IGF2, and H19
W Hartmann et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
